These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
713 related articles for article (PubMed ID: 26642438)
1. PPAR-δ is repressed in Huntington's disease, is required for normal neuronal function and can be targeted therapeutically. Dickey AS; Pineda VV; Tsunemi T; Liu PP; Miranda HC; Gilmore-Hall SK; Lomas N; Sampat KR; Buttgereit A; Torres MJ; Flores AL; Arreola M; Arbez N; Akimov SS; Gaasterland T; Lazarowski ER; Ross CA; Yeo GW; Sopher BL; Magnuson GK; Pinkerton AB; Masliah E; La Spada AR Nat Med; 2016 Jan; 22(1):37-45. PubMed ID: 26642438 [TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of PPAR-γ agonist rosiglitazone in N171-82Q mouse model of Huntington's disease. Jin J; Albertz J; Guo Z; Peng Q; Rudow G; Troncoso JC; Ross CA; Duan W J Neurochem; 2013 May; 125(3):410-9. PubMed ID: 23373812 [TBL] [Abstract][Full Text] [Related]
3. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease. Zhang H; Li Q; Graham RK; Slow E; Hayden MR; Bezprozvanny I Neurobiol Dis; 2008 Jul; 31(1):80-8. PubMed ID: 18502655 [TBL] [Abstract][Full Text] [Related]
4. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease. Hermel E; Gafni J; Propp SS; Leavitt BR; Wellington CL; Young JE; Hackam AS; Logvinova AV; Peel AL; Chen SF; Hook V; Singaraja R; Krajewski S; Goldsmith PC; Ellerby HM; Hayden MR; Bredesen DE; Ellerby LM Cell Death Differ; 2004 Apr; 11(4):424-38. PubMed ID: 14713958 [TBL] [Abstract][Full Text] [Related]
5. In vivo cell-autonomous transcriptional abnormalities revealed in mice expressing mutant huntingtin in striatal but not cortical neurons. Thomas EA; Coppola G; Tang B; Kuhn A; Kim S; Geschwind DH; Brown TB; Luthi-Carter R; Ehrlich ME Hum Mol Genet; 2011 Mar; 20(6):1049-60. PubMed ID: 21177255 [TBL] [Abstract][Full Text] [Related]
6. Antisense oligonucleotide-mediated correction of transcriptional dysregulation is correlated with behavioral benefits in the YAC128 mouse model of Huntington's disease. Stanek LM; Yang W; Angus S; Sardi PS; Hayden MR; Hung GH; Bennett CF; Cheng SH; Shihabuddin LS J Huntingtons Dis; 2013; 2(2):217-28. PubMed ID: 25063516 [TBL] [Abstract][Full Text] [Related]
7. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD). Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346 [TBL] [Abstract][Full Text] [Related]
8. PPARδ activation by bexarotene promotes neuroprotection by restoring bioenergetic and quality control homeostasis. Dickey AS; Sanchez DN; Arreola M; Sampat KR; Fan W; Arbez N; Akimov S; Van Kanegan MJ; Ohnishi K; Gilmore-Hall SK; Flores AL; Nguyen JM; Lomas N; Hsu CL; Lo DC; Ross CA; Masliah E; Evans RM; La Spada AR Sci Transl Med; 2017 Dec; 9(419):. PubMed ID: 29212711 [TBL] [Abstract][Full Text] [Related]
9. Wild-type huntingtin ameliorates striatal neuronal atrophy but does not prevent other abnormalities in the YAC128 mouse model of Huntington disease. Van Raamsdonk JM; Pearson J; Murphy Z; Hayden MR; Leavitt BR BMC Neurosci; 2006 Dec; 7():80. PubMed ID: 17147801 [TBL] [Abstract][Full Text] [Related]
10. The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease. Doria JG; de Souza JM; Andrade JN; Rodrigues HA; Guimaraes IM; Carvalho TG; Guatimosim C; Dobransky T; Ribeiro FM Neurobiol Dis; 2015 Jan; 73():163-73. PubMed ID: 25160573 [TBL] [Abstract][Full Text] [Related]
11. Msh2 acts in medium-spiny striatal neurons as an enhancer of CAG instability and mutant huntingtin phenotypes in Huntington's disease knock-in mice. Kovalenko M; Dragileva E; St Claire J; Gillis T; Guide JR; New J; Dong H; Kucherlapati R; Kucherlapati MH; Ehrlich ME; Lee JM; Wheeler VC PLoS One; 2012; 7(9):e44273. PubMed ID: 22970194 [TBL] [Abstract][Full Text] [Related]
12. AMPK-α1 functions downstream of oxidative stress to mediate neuronal atrophy in Huntington's disease. Ju TC; Chen HM; Chen YC; Chang CP; Chang C; Chern Y Biochim Biophys Acta; 2014 Sep; 1842(9):1668-80. PubMed ID: 24946181 [TBL] [Abstract][Full Text] [Related]
13. Loss of huntingtin function slows synaptic vesicle endocytosis in striatal neurons from the htt McAdam RL; Morton A; Gordon SL; Alterman JF; Khvorova A; Cousin MA; Smillie KJ Neurobiol Dis; 2020 Feb; 134():104637. PubMed ID: 31614197 [TBL] [Abstract][Full Text] [Related]
14. Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype. Wegrzynowicz M; Bichell TJ; Soares BD; Loth MK; McGlothan JS; Mori S; Alikhan FS; Hua K; Coughlin JM; Holt HK; Jetter CS; Pomper MG; Osmand AP; Guilarte TR; Bowman AB J Huntingtons Dis; 2015; 4(1):17-36. PubMed ID: 26333255 [TBL] [Abstract][Full Text] [Related]
15. The dysfunction of hepatic transcriptional factors in mice with Huntington's Disease. Chiang MC; Chern Y; Juo CG Biochim Biophys Acta; 2011 Sep; 1812(9):1111-20. PubMed ID: 21651979 [TBL] [Abstract][Full Text] [Related]
16. Adenovirus vector-based in vitro neuronal cell model for Huntington's disease with human disease-like differential aggregation and degeneration. Dong X; Zong S; Witting A; Lindenberg KS; Kochanek S; Huang B J Gene Med; 2012 Jul; 14(7):468-81. PubMed ID: 22700462 [TBL] [Abstract][Full Text] [Related]
17. Effects of overexpression of huntingtin proteins on mitochondrial integrity. Wang H; Lim PJ; Karbowski M; Monteiro MJ Hum Mol Genet; 2009 Feb; 18(4):737-52. PubMed ID: 19039036 [TBL] [Abstract][Full Text] [Related]
18. Inducing huntingtin inclusion formation in primary neuronal cell culture and in vivo by high-capacity adenoviral vectors expressing truncated and full-length huntingtin with polyglutamine expansion. Huang B; Schiefer J; Sass C; Kosinski CM; Kochanek S J Gene Med; 2008 Mar; 10(3):269-79. PubMed ID: 18067195 [TBL] [Abstract][Full Text] [Related]
19. PPARgamma rescue of the mitochondrial dysfunction in Huntington's disease. Chiang MC; Chern Y; Huang RN Neurobiol Dis; 2012 Jan; 45(1):322-8. PubMed ID: 21907283 [TBL] [Abstract][Full Text] [Related]
20. Transducer of regulated CREB-binding proteins (TORCs) transcription and function is impaired in Huntington's disease. Chaturvedi RK; Hennessey T; Johri A; Tiwari SK; Mishra D; Agarwal S; Kim YS; Beal MF Hum Mol Genet; 2012 Aug; 21(15):3474-88. PubMed ID: 22589249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]